B. Riley Securities Maintains Buy on ClearPoint Neuro, Raises Price Target to $20

B. Riley Securities analyst Neil Chatterji maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and raises the price target from $18 to $20.